Compile Data Set for Download or QSAR

Found 240 hits with Last Name = 'padia' and Initial = 'jk'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50073729 ((R)-3-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...) Show SMILES C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H](CC(O)=O)Cc1ccccc1 |wU:1.1,wD:29.33,1.0,TLB:25:24:22:19.18.20,15:16:19.18.25:21.22.23,THB:25:19:22:16.24.23,20:19:16:21.22.23,20:21:16:19.18.25,15:16:22:19.18.20,(11.34,-6.2,;12.13,-7.56,;10.6,-7.56,;9.84,-8.91,;10.31,-10.38,;9.07,-11.27,;7.83,-10.38,;6.34,-10.7,;5.31,-9.55,;5.77,-8.08,;7.29,-7.76,;8.31,-8.92,;13.69,-10.86,;15.23,-10.87,;16.01,-9.52,;16.01,-12.2,;17.86,-12.93,;17.78,-14.48,;19.32,-15.08,;20.87,-14.55,;21.77,-15.87,;20.15,-15.13,;18.69,-15.64,;20.18,-13.68,;19.37,-12.43,;20.96,-12.99,;12.89,-6.23,;12.13,-4.9,;14.44,-6.23,;15.2,-4.88,;16.74,-4.88,;17.5,-6.2,;19.02,-6.2,;16.74,-7.53,;14.42,-3.55,;15.18,-2.23,;14.38,-.91,;15.15,.42,;16.69,.43,;17.46,-.89,;16.7,-2.23,)| Show InChI InChI=1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article	n/a	n/a	0.150	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description In vitro inhibition of [125I]- Bolton Hunter CCK-8 binding to Cholecystokinin type B receptor in the mouse cerebral cortex.				Bioorg Med Chem Lett 3: 2805-2810 (1993) Article DOI: 10.1016/S0960-894X(01)80769-1 BindingDB Entry DOI: 10.7270/Q29Z94TW
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062005 ((S)-3-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@H](CC(O)=O)Cc1ccccc1 |wU:1.13,wD:29.33,1.0,TLB:15:16:18:21.22.20,THB:23:24:18:21.22.20,23:21:18:16.24.25,20:21:16:19.18.25,20:19:16:21.23.22,(10.8,-2.25,;10.81,-3.63,;10.9,-5.18,;12.26,-5.88,;11.02,-6.79,;11.49,-8.25,;13.03,-8.24,;14.06,-9.39,;15.56,-9.07,;16.04,-7.61,;15.01,-6.46,;13.52,-6.79,;9.43,-3.12,;8.15,-3.96,;8.17,-5.43,;6.76,-3.28,;5.47,-4.12,;5.46,-5.67,;4.44,-6.95,;3.04,-6.37,;1.53,-6.79,;2.74,-5.52,;4.05,-6.01,;2.72,-4.03,;4.08,-3.55,;3.02,-4.78,;12.1,-2.95,;12.07,-1.57,;13.48,-3.63,;14.76,-2.78,;14.67,-1.25,;15.43,.09,;14.65,1.43,;16.98,.11,;16.14,-3.47,;17.43,-2.62,;17.34,-1.25,;18.6,-.23,;20,-.92,;20.1,-2.46,;18.81,-3.31,)| Show InChI InChI=1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.150	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062000 (2-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-in...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NC1CCCCC1C(O)=O |wU:1.13,wD:1.0,TLB:15:16:23:19.25.20,18:19:23:16.17.22,THB:18:17:23:19.25.20,20:21:16:19.18.25,20:19:16:21.23.22,(1.86,-7.02,;1.88,-8.39,;1.95,-9.94,;3.33,-10.64,;2.08,-11.55,;2.56,-13.03,;4.11,-13.02,;5.13,-14.17,;6.63,-13.85,;7.1,-12.37,;6.07,-11.24,;4.57,-11.55,;.49,-7.88,;-.8,-8.73,;-.77,-10.19,;-2.19,-8.04,;-3.48,-8.9,;-3.48,-10.43,;-4.51,-11.72,;-5.92,-11.15,;-7.41,-11.57,;-6.22,-10.29,;-4.89,-10.78,;-6.22,-8.8,;-4.87,-8.32,;-5.92,-9.55,;3.16,-7.71,;3.15,-6.33,;4.41,-8.44,;5.74,-7.68,;7.08,-8.44,;8.41,-7.69,;8.43,-6.14,;7.08,-5.37,;5.74,-6.13,;4.64,-5.03,;5.04,-3.54,;3.15,-5.42,)| Show InChI InChI=1S/C30H39N3O5/c1-30(15-21-16-31-24-8-4-2-6-22(21)24,28(36)32-25-9-5-3-7-23(25)27(34)35)33-29(37)38-26-19-11-17-10-18(13-19)14-20(26)12-17/h2,4,6,8,16-20,23,25-26,31H,3,5,7,9-15H2,1H3,(H,32,36)(H,33,37)(H,34,35)/t17?,18?,19?,20?,23?,25?,26?,30-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.990	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063665 (CHEMBL9203 | N-(3-nitrophenyl)-2-[3,4-dihydro-3-[3...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)[N+]([O-])=O)nc2ccccc2c1=O Show InChI InChI=1S/C24H22N6O5/c1-15(2)35-19-10-6-8-17(14-19)29-22(31)20-11-3-4-12-21(20)26-23(29)27-28-24(32)25-16-7-5-9-18(13-16)30(33)34/h3-15H,1-2H3,(H,26,27)(H2,25,28,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063640 (CHEMBL9405 | N-(3-cyanobenzene)-2-[3,4-dihydro-3-[...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)C#N)nc2ccccc2c1=O Show InChI InChI=1S/C25H22N6O3/c1-16(2)34-20-10-6-9-19(14-20)31-23(32)21-11-3-4-12-22(21)28-24(31)29-30-25(33)27-18-8-5-7-17(13-18)15-26/h3-14,16H,1-2H3,(H,28,29)(H2,27,30,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063630 (CHEMBL9188 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OC(C)C)c2)c1 Show InChI InChI=1S/C27H27N5O5/c1-4-36-25(34)18-9-7-10-19(15-18)28-27(35)31-30-26-29-23-14-6-5-13-22(23)24(33)32(26)20-11-8-12-21(16-20)37-17(2)3/h5-17H,4H2,1-3H3,(H,29,30)(H2,28,31,35)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50449787 (CHEMBL2062154 | PD-134308) Show SMILES [H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)C(OC(=O)N[C@](C)(Cc1c[nH]c4ccccc14)C(=O)NC[C@H](NC(=O)CCC(O)=O)c1ccccc1)[C@@]([H])(C2)C3 |wU:30.41,14.15,45.49,3.3,wD:6.6,1.0,TLB:5:3:47:9.6.8,10:9:47:3.48.2,THB:5:6:47:3.48.2,10:9:1.47.8:3.5.48,2:3:9:1.47.8,2:1:9:3.5.48,(-14.99,-2.1,;-13.56,-2.66,;-14.77,-3.94,;-13.26,-3.53,;-13.35,-5.06,;-11.86,-4.09,;-10.83,-2.82,;-9.38,-3.33,;-12.24,-3.16,;-10.83,-1.28,;-9.29,-1.31,;-8.5,.01,;-9.25,1.36,;-6.96,-.01,;-6.19,1.3,;-5.42,-.02,;-7.44,2.2,;-7.28,3.74,;-8.44,4.76,;-7.81,6.18,;-6.29,6.03,;-5.14,7.07,;-3.69,6.6,;-3.34,5.08,;-4.49,4.06,;-5.94,4.52,;-4.66,1.42,;-3.99,2.8,;-3.79,.15,;-2.27,.27,;-1.4,-1.02,;-2.08,-2.4,;-1.22,-3.69,;.32,-3.58,;-1.9,-5.07,;-3.43,-5.16,;-4.1,-6.57,;-5.64,-6.67,;-3.25,-7.83,;.14,-.91,;.99,-2.2,;2.51,-2.08,;3.19,-.7,;2.32,.59,;.8,.47,;-12.23,-.7,;-12.2,.82,;-13.58,-1.18,;-13.27,-1.94,)| Show InChI InChI=1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21-,22+,24-,25+,29-,32?,35+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50449747 (CHEMBL2304062) Show SMILES [H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)C(OC(=O)N[C@@](C)(Cc1c[nH]c4ccccc14)C(=O)NC[C@@H](NC(=O)CCC(O)=O)c1ccccc1)[C@@]([H])(C2)C3 |wU:3.3,6.6,14.16,wD:45.49,1.0,30.41,TLB:8:6:48:1.47.2,8:1:48:9.6.5,THB:10:9:48:1.47.2,2:3:9:1.8.47,2:1:9:3.48.5,(9.27,-3.28,;10.78,-3.02,;9.99,-1.76,;10.9,-.65,;10.13,.67,;10.64,-2.25,;11.48,-3.6,;12.2,-4.96,;10.41,-4.75,;12.97,-3.35,;13.98,-4.49,;15.5,-4.18,;15.98,-2.72,;16.54,-5.32,;18.04,-4.99,;19.38,-4.22,;18.9,-2.94,;18.2,-1.17,;19.34,-.14,;18.71,1.27,;17.18,1.11,;16.04,2.14,;14.57,1.66,;14.25,.16,;15.4,-.87,;16.86,-.4,;19.08,-6.13,;18.61,-7.6,;20.59,-5.8,;21.62,-6.94,;23.13,-6.61,;24.17,-7.75,;25.67,-7.42,;26.14,-5.95,;26.71,-8.56,;28.21,-8.23,;29.25,-9.37,;30.75,-9.04,;28.78,-10.83,;23.59,-5.14,;25.1,-4.81,;25.57,-3.35,;24.53,-2.21,;23.02,-2.54,;22.56,-4,;13.18,-1.74,;14.68,-1.42,;12.16,-2.75,;12.39,-.42,)| Show InChI InChI=1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21-,22+,24-,25+,29-,32?,35+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description In vitro inhibition of [125I]- Bolton Hunter CCK-8 binding to Cholecystokinin type B receptor in the mouse cerebral cortex.				Bioorg Med Chem Lett 3: 2805-2810 (1993) Article DOI: 10.1016/S0960-894X(01)80769-1 BindingDB Entry DOI: 10.7270/Q29Z94TW
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063616 (CHEMBL8890 | N-(3-tert-butylbenzoicacid)-2-[3,4-di...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)C(=O)OC(C)(C)C)nc2ccccc2c1=O Show InChI InChI=1S/C29H31N5O5/c1-18(2)38-22-13-9-12-21(17-22)34-25(35)23-14-6-7-15-24(23)31-27(34)32-33-28(37)30-20-11-8-10-19(16-20)26(36)39-29(3,4)5/h6-18H,1-5H3,(H,31,32)(H2,30,33,37)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.90	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50281284 (CHEMBL433384 | [[(S)-2-(Adamantan-2-yloxycarbonyla...) Show SMILES C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N(CCc1ccccn1)CC(O)=O |wU:19.20,1.0,wD:1.13,21.28,17.19,23.24,THB:18:19:22:16.17.25,20:21:16:19.18.24,20:19:16:21.22.25,(6.89,-3.2,;6.89,-4.74,;6.89,-6.28,;6.42,-7.75,;7.33,-8.98,;6.42,-10.24,;4.95,-9.76,;3.62,-10.55,;2.29,-9.78,;2.29,-8.22,;3.62,-7.45,;4.95,-8.22,;5.4,-5.13,;4.35,-3.99,;4.81,-2.52,;2.85,-4.3,;1.83,-3.16,;2.04,-1.54,;1.01,-2.57,;-.37,-2.83,;-1.16,-1.56,;-.25,-.47,;-.51,-2.05,;.33,-3.41,;-.74,-4.55,;1.24,-.23,;8.38,-4.34,;8.78,-2.85,;9.46,-5.42,;10.95,-5.02,;12.05,-6.11,;13.52,-5.72,;14.61,-6.81,;16.08,-6.42,;16.48,-4.95,;15.41,-3.85,;13.91,-4.25,;9.06,-6.91,;10.16,-8,;11.7,-7.85,;9.53,-9.4,)| Show InChI InChI=1S/C32H38N4O5/c1-32(17-24-18-34-27-8-3-2-7-26(24)27,30(39)36(19-28(37)38)11-9-25-6-4-5-10-33-25)35-31(40)41-29-22-13-20-12-21(15-22)16-23(29)14-20/h2-8,10,18,20-23,29,34H,9,11-17,19H2,1H3,(H,35,40)(H,37,38)/t20-,21+,22-,23+,29?,32-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description In vitro inhibition of [125I]- Bolton Hunter CCK-8 binding to Cholecystokinin type B receptor in the mouse cerebral cortex.				Bioorg Med Chem Lett 3: 2805-2810 (1993) Article DOI: 10.1016/S0960-894X(01)80769-1 BindingDB Entry DOI: 10.7270/Q29Z94TW
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063666 (CHEMBL266557 | N-(3-ethylesterbenzoicacid)-2-[3,4-...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2ccc(Cl)c(Cl)c2)c1 Show InChI InChI=1S/C24H19Cl2N5O4/c1-2-35-22(33)14-6-5-7-15(12-14)27-24(34)30-29-23-28-20-9-4-3-8-17(20)21(32)31(23)16-10-11-18(25)19(26)13-16/h3-13H,2H2,1H3,(H,28,29)(H2,27,30,34)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.40	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062003 (CHEMBL138233 | [(R)-2-(1H-Indol-3-yl)-1-((R)-2-met...) Show SMILES COC[C@H]1CCCN1NC(=O)[C@@](C)(Cc1c[nH]c2ccccc12)NC(=O)OC1C2CC3CC(C2)CC1C3 |wU:11.25,wD:11.12,3.2,TLB:36:35:33:30.29.31,THB:36:30:27.35.34:33,31:32:27:30.29.36,31:30:27:32.34.33,26:27:33:30.29.31,(8.73,-11.26,;8.31,-9.76,;6.82,-9.39,;6.39,-7.89,;7.35,-6.69,;6.5,-5.4,;5.01,-5.81,;4.94,-7.37,;3.66,-8.22,;2.42,-7.49,;2.39,-6.11,;1.13,-8.17,;1.12,-6.79,;1.22,-9.72,;2.58,-10.42,;1.34,-11.33,;1.81,-12.8,;3.35,-12.78,;4.38,-13.93,;5.88,-13.62,;6.36,-12.15,;5.33,-11,;3.84,-11.33,;-.25,-7.66,;-1.54,-8.5,;-1.51,-9.97,;-2.92,-7.82,;-4.21,-8.66,;-4.23,-10.21,;-5.63,-10.55,;-6.95,-10.06,;-8.16,-11.33,;-6.64,-10.91,;-5.24,-11.49,;-6.66,-9.32,;-5.61,-8.08,;-6.96,-8.57,)| Show InChI InChI=1S/C29H40N4O4/c1-29(15-22-16-30-25-8-4-3-7-24(22)25,27(34)32-33-9-5-6-23(33)17-36-2)31-28(35)37-26-20-11-18-10-19(13-20)14-21(26)12-18/h3-4,7-8,16,18-21,23,26,30H,5-6,9-15,17H2,1-2H3,(H,31,35)(H,32,34)/t18?,19?,20?,21?,23-,26?,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061997 (CHEMBL138084 | [(R)-1-((1R,2R)-2-Hydroxy-cyclohexy...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H]1CCCC[C@H]1O |wU:1.13,29.33,wD:34.40,1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:21:16:19.18.25,20:19:16:21.23.22,15:16:22:19.18.20,(8.08,-2.21,;8.11,-3.57,;8.18,-5.11,;9.56,-5.81,;8.32,-6.72,;8.78,-8.2,;10.33,-8.2,;11.36,-9.35,;12.86,-9.02,;13.32,-7.54,;12.29,-6.42,;10.8,-6.72,;6.72,-3.05,;5.44,-3.92,;5.46,-5.37,;4.03,-3.21,;2.75,-4.08,;2.75,-5.6,;1.34,-5.95,;.01,-5.46,;-1.19,-6.75,;.31,-6.33,;1.72,-6.89,;.31,-4.74,;1.37,-3.49,;.01,-3.99,;9.39,-2.89,;9.37,-1.51,;10.63,-3.61,;11.97,-2.86,;13.3,-3.61,;14.63,-2.86,;14.66,-1.32,;13.3,-.55,;11.97,-1.32,;10.87,-.22,)| Show InChI InChI=1S/C29H39N3O4/c1-29(27(34)31-24-8-4-5-9-25(24)33,15-21-16-30-23-7-3-2-6-22(21)23)32-28(35)36-26-19-11-17-10-18(13-19)14-20(26)12-17/h2-3,6-7,16-20,24-26,30,33H,4-5,8-15H2,1H3,(H,31,34)(H,32,35)/t17?,18?,19?,20?,24-,25-,26?,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061994 (CHEMBL138112 | [(R)-1-(2-Cyano-cyclohexylcarbamoyl...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NC1CCCCC1C#N |wU:1.13,wD:1.0,TLB:18:19:16.17.22:23,15:16:23:19.25.20,THB:18:17:23:19.25.20,20:19:16:21.22.23,20:21:16:19.18.25,(1.86,-7.02,;1.88,-8.39,;1.95,-9.94,;3.33,-10.64,;2.08,-11.55,;2.56,-13.03,;4.11,-13.02,;5.13,-14.17,;6.63,-13.85,;7.1,-12.37,;6.07,-11.24,;4.57,-11.55,;.49,-7.88,;-.8,-8.73,;-.77,-10.19,;-2.19,-8.04,;-3.48,-8.9,;-4.87,-8.32,;-6.22,-8.8,;-6.22,-10.29,;-7.41,-11.57,;-5.92,-11.15,;-5.92,-9.55,;-4.51,-11.72,;-3.48,-10.43,;-4.89,-10.78,;3.16,-7.71,;3.15,-6.33,;4.41,-8.44,;5.74,-7.68,;7.08,-8.44,;8.41,-7.69,;8.43,-6.14,;7.08,-5.37,;5.74,-6.13,;4.64,-5.03,;3.54,-3.93,)| Show InChI InChI=1S/C30H38N4O3/c1-30(15-23-17-32-26-9-5-3-7-24(23)26,28(35)33-25-8-4-2-6-20(25)16-31)34-29(36)37-27-21-11-18-10-19(13-21)14-22(27)12-18/h3,5,7,9,17-22,25,27,32H,2,4,6,8,10-15H2,1H3,(H,33,35)(H,34,36)/t18?,19?,20?,21?,22?,25?,27?,30-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	3.5	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062006 (CHEMBL344882 | [(R)-1-((1R,2R)-2-Hydroxy-cyclohept...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H]1CCCCC[C@H]1O |wU:1.13,29.33,wD:35.41,1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:21:16:19.18.25,20:19:16:21.23.22,15:16:22:19.18.20,(9.7,-1.95,;9.72,-3.31,;9.79,-4.86,;11.17,-5.56,;9.92,-6.47,;10.4,-7.95,;11.95,-7.95,;12.96,-9.1,;14.48,-8.77,;14.95,-7.29,;13.92,-6.17,;12.42,-6.47,;8.32,-2.8,;7.04,-3.66,;7.06,-5.11,;5.65,-2.96,;4.34,-3.83,;4.34,-5.35,;2.95,-5.7,;1.62,-5.21,;.42,-6.5,;1.92,-6.08,;3.33,-6.64,;1.92,-4.48,;2.96,-3.24,;1.62,-3.73,;10.99,-2.63,;10.99,-1.25,;12.25,-3.36,;13.59,-2.61,;14.86,-3.47,;16.34,-3.01,;16.9,-1.58,;16.14,-.24,;14.6,-.01,;13.47,-1.04,;12.04,-.48,)| Show InChI InChI=1S/C30H41N3O4/c1-30(16-22-17-31-24-8-6-5-7-23(22)24,28(35)32-25-9-3-2-4-10-26(25)34)33-29(36)37-27-20-12-18-11-19(14-20)15-21(27)13-18/h5-8,17-21,25-27,31,34H,2-4,9-16H2,1H3,(H,32,35)(H,33,36)/t18?,19?,20?,21?,25-,26-,27?,30-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063636 (CHEMBL9406 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(c2)N(C)C)c1 Show InChI InChI=1S/C26H26N6O4/c1-4-36-24(34)17-9-7-10-18(15-17)27-26(35)30-29-25-28-22-14-6-5-13-21(22)23(33)32(25)20-12-8-11-19(16-20)31(2)3/h5-16H,4H2,1-3H3,(H,28,29)(H2,27,30,35)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063661 (CHEMBL9267 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OCC)c2)c1 Show InChI InChI=1S/C26H25N5O5/c1-3-35-20-12-8-11-19(16-20)31-23(32)21-13-5-6-14-22(21)28-25(31)29-30-26(34)27-18-10-7-9-17(15-18)24(33)36-4-2/h5-16H,3-4H2,1-2H3,(H,28,29)(H2,27,30,34)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063650 (CHEMBL275307 | N-(3-benzonitrile)-2-[3,4-dihydro-3...) Show SMILES CCOc1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)C#N)nc2ccccc2c1=O Show InChI InChI=1S/C24H20N6O3/c1-2-33-19-10-6-9-18(14-19)30-22(31)20-11-3-4-12-21(20)27-23(30)28-29-24(32)26-17-8-5-7-16(13-17)15-25/h3-14H,2H2,1H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.80	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063644 (CHEMBL276627 | N-(3-chlorophenyl)-2-[3,4-dihydro-3...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(Cl)c2)nc2ccccc2c1=O Show InChI InChI=1S/C24H22ClN5O3/c1-15(2)33-19-10-6-9-18(14-19)30-22(31)20-11-3-4-12-21(20)27-23(30)28-29-24(32)26-17-8-5-7-16(25)13-17/h3-15H,1-2H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.90	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062001 (CHEMBL344380 | [(R)-1-(2-Hydroxy-cyclohexylcarbamo...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NC1CCCCC1O |wU:1.13,wD:1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:21:16:19.18.25,20:19:16:21.23.22,15:16:22:19.18.20,(10.96,-3.48,;10.98,-4.85,;11.05,-6.4,;12.43,-7.1,;11.18,-8.02,;11.66,-9.49,;13.21,-9.48,;14.23,-10.63,;15.74,-10.31,;16.21,-8.84,;15.17,-7.7,;13.67,-8.02,;9.59,-4.34,;8.3,-5.19,;8.32,-6.66,;6.9,-4.5,;5.61,-5.35,;5.61,-6.89,;4.2,-7.24,;2.87,-6.75,;1.67,-8.02,;3.17,-7.6,;4.58,-8.18,;3.17,-6.01,;4.22,-4.78,;2.87,-5.26,;12.26,-4.17,;12.24,-2.79,;13.51,-4.9,;14.85,-4.13,;16.18,-4.9,;17.52,-4.15,;17.53,-2.6,;16.18,-1.83,;14.85,-2.59,;13.74,-1.48,)| Show InChI InChI=1S/C29H39N3O4/c1-29(27(34)31-24-8-4-5-9-25(24)33,15-21-16-30-23-7-3-2-6-22(21)23)32-28(35)36-26-19-11-17-10-18(13-19)14-20(26)12-17/h2-3,6-7,16-20,24-26,30,33H,4-5,8-15H2,1H3,(H,31,34)(H,32,35)/t17?,18?,19?,20?,24?,25?,26?,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.20	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061988 (CHEMBL138657 | [(R)-1-((S)-1-Hydroxymethyl-2-pheny...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@H](CO)Cc1ccccc1 |wU:1.13,wD:29.33,1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:19:16:21.23.22,20:21:16:19.18.25,15:16:22:19.18.20,(-.04,-8.98,;-.02,-10.34,;.05,-11.88,;1.42,-12.58,;.17,-13.49,;.65,-14.96,;2.19,-14.95,;3.2,-16.09,;4.71,-15.77,;5.18,-14.3,;4.16,-13.18,;2.67,-13.49,;-1.41,-9.83,;-2.7,-10.68,;-2.67,-12.13,;-4.07,-9.99,;-5.36,-10.84,;-5.36,-12.37,;-6.76,-12.72,;-8.08,-12.23,;-9.28,-13.5,;-7.78,-13.08,;-6.38,-13.65,;-7.79,-11.5,;-6.75,-10.27,;-8.11,-10.75,;1.24,-9.66,;1.24,-8.29,;2.62,-10.35,;3.9,-9.5,;3.81,-7.96,;4.58,-6.63,;5.28,-10.19,;6.56,-9.34,;6.48,-7.96,;7.74,-6.96,;9.13,-7.63,;9.22,-9.17,;7.94,-10.03,)| Show InChI InChI=1S/C32H39N3O4/c1-32(17-25-18-33-28-10-6-5-9-27(25)28,30(37)34-26(19-36)16-20-7-3-2-4-8-20)35-31(38)39-29-23-12-21-11-22(14-23)15-24(29)13-21/h2-10,18,21-24,26,29,33,36H,11-17,19H2,1H3,(H,34,37)(H,35,38)/t21?,22?,23?,24?,26-,29?,32+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.30	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061993 (CHEMBL337529 | [(R)-1-(3-Aza-bicyclo[3.2.2]non-3-y...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NN1CC2CCC(CC2)C1 |wU:1.13,wD:1.0,TLB:18:19:16.17.22:23,15:16:23:19.25.20,THB:18:17:23:19.25.20,20:21:16:19.18.25,20:19:16:21.22.23,(1.12,-6.79,;1.13,-8.18,;1.22,-9.72,;2.58,-10.42,;1.34,-11.33,;1.81,-12.8,;3.35,-12.79,;4.38,-13.93,;5.88,-13.62,;6.37,-12.15,;5.34,-11.01,;3.85,-11.33,;-.25,-7.66,;-1.54,-8.5,;-1.51,-9.98,;-2.93,-7.82,;-4.21,-8.67,;-5.61,-8.08,;-6.97,-8.57,;-6.95,-10.06,;-8.16,-11.33,;-6.65,-10.91,;-6.66,-9.32,;-5.24,-11.49,;-4.23,-10.21,;-5.63,-10.55,;2.42,-7.5,;2.39,-6.12,;3.66,-8.22,;4.95,-7.37,;6.28,-8.17,;7.73,-7.61,;8.2,-6.14,;7.33,-4.85,;5.79,-4.73,;5.79,-6.27,;6.55,-7.61,;4.74,-5.85,)| Show InChI InChI=1S/C31H42N4O3/c1-31(15-25-16-32-27-5-3-2-4-26(25)27,29(36)34-35-17-19-6-7-20(18-35)9-8-19)33-30(37)38-28-23-11-21-10-22(13-23)14-24(28)12-21/h2-5,16,19-24,28,32H,6-15,17-18H2,1H3,(H,33,37)(H,34,36)/t19?,20?,21?,22?,23?,24?,28?,31-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.5	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063662 (CHEMBL9534 | N-(3-Methoxy-phenyl)-N-[(methyl-pheny...) Show SMILES COc1cccc(c1)N(CC(=O)N(C)c1ccccc1)C(=O)CNC(=O)Nc1cccc(C)c1 Show InChI InChI=1S/C26H28N4O4/c1-19-9-7-10-20(15-19)28-26(33)27-17-24(31)30(22-13-8-14-23(16-22)34-3)18-25(32)29(2)21-11-5-4-6-12-21/h4-16H,17-18H2,1-3H3,(H2,27,28,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063629 (3-[3-((R)-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-b...) Show SMILES COC(=O)c1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1 |t:14| Show InChI InChI=1S/C25H22N4O4/c1-29-20-14-7-6-13-19(20)21(16-9-4-3-5-10-16)27-22(23(29)30)28-25(32)26-18-12-8-11-17(15-18)24(31)33-2/h3-15,22H,1-2H3,(H2,26,28,32)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063614 (CHEMBL8954 | N-(3-trifluoromethylphenyl)-2-[3,4-di...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)C(F)(F)F)nc2ccccc2c1=O Show InChI InChI=1S/C25H22F3N5O3/c1-15(2)36-19-10-6-9-18(14-19)33-22(34)20-11-3-4-12-21(20)30-23(33)31-32-24(35)29-17-8-5-7-16(13-17)25(26,27)28/h3-15H,1-2H3,(H,30,31)(H2,29,32,35)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50006878 ((R)-1-(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benz...) Show SMILES CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2ccc(C)cc2)C1=O)c1ccccc1 |c:9| Show InChI InChI=1S/C24H22N4O2/c1-16-12-14-18(15-13-16)25-24(30)27-22-23(29)28(2)20-11-7-6-10-19(20)21(26-22)17-8-4-3-5-9-17/h3-15,22H,1-2H3,(H2,25,27,30)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	8.5	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of [125 I]CCK-8 binding to Cholecystokinin type B receptor of mouse cerebral cortex				Bioorg Med Chem Lett 7: 805-810 (1997) Article DOI: 10.1016/S0960-894X(97)00108-X BindingDB Entry DOI: 10.7270/Q2XW4JTV
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50006878 ((R)-1-(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benz...) Show SMILES CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2ccc(C)cc2)C1=O)c1ccccc1 |c:9| Show InChI InChI=1S/C24H22N4O2/c1-16-12-14-18(15-13-16)25-24(30)27-22-23(29)28(2)20-11-7-6-10-19(20)21(26-22)17-8-4-3-5-9-17/h3-15,22H,1-2H3,(H2,25,27,30)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.5	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50281277 ((R)-3-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N[C@@H](CC(O)=O)Cc1ccccc1 |wU:1.13,29.33,21.23,23.26,wD:19.27,17.19,1.0,THB:22:21:16.23.24:18,20:21:16:19.24.18,20:19:16:21.22.25,(9.25,-3.09,;9.25,-4.63,;9.25,-6.16,;8.78,-7.64,;9.69,-8.88,;8.78,-10.13,;7.31,-9.64,;5.97,-10.43,;4.65,-9.67,;4.65,-8.13,;5.97,-7.34,;7.31,-8.11,;7.75,-5.02,;6.69,-3.88,;7.18,-2.41,;5.18,-4.19,;4.19,-3.04,;2.69,-3.3,;1.84,-1.95,;2.1,-.36,;1.19,-1.45,;1.98,-2.72,;3.37,-2.45,;4.4,-1.42,;3.6,-.12,;1.61,-4.44,;10.73,-4.23,;11.13,-2.74,;11.82,-5.3,;13.3,-4.91,;13.7,-3.44,;15.19,-3.02,;15.58,-1.54,;16.28,-4.12,;14.4,-6,;15.86,-5.6,;15.86,-7.15,;17.2,-7.92,;18.53,-7.16,;18.53,-5.6,;17.2,-4.86,)| Show InChI InChI=1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21-,22+,23-,24+,26-,30?,33-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	9.30	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description In vitro inhibition of [125I]- Bolton Hunter CCK-8 binding to Cholecystokinin type B receptor in the mouse cerebral cortex.				Bioorg Med Chem Lett 3: 2805-2810 (1993) Article DOI: 10.1016/S0960-894X(01)80769-1 BindingDB Entry DOI: 10.7270/Q29Z94TW
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063641 (2-[2-(6-Bromo-1H-indol-3-yl)-ethyl]-3-(3-isopropox...) Show SMILES CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3cc(Br)ccc23)nc2ccccc2c1=O Show InChI InChI=1S/C27H24BrN3O2/c1-17(2)33-21-7-5-6-20(15-21)31-26(30-24-9-4-3-8-23(24)27(31)32)13-10-18-16-29-25-14-19(28)11-12-22(18)25/h3-9,11-12,14-17,29H,10,13H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9.30	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061990 ((R)-3-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H](CC(O)=O)Cc1ccccc1 |wU:1.13,29.33,wD:1.0,TLB:15:16:18:21.22.20,THB:23:24:18:21.22.20,23:21:18:16.24.25,20:21:16:19.18.25,20:19:16:21.23.22,(10.8,-2.25,;10.81,-3.63,;10.9,-5.18,;12.26,-5.88,;11.02,-6.79,;11.49,-8.25,;13.03,-8.24,;14.06,-9.39,;15.56,-9.07,;16.04,-7.61,;15.01,-6.46,;13.52,-6.79,;9.43,-3.12,;8.15,-3.96,;8.17,-5.43,;6.76,-3.28,;5.47,-4.12,;5.46,-5.67,;4.44,-6.95,;3.04,-6.37,;1.53,-6.79,;2.74,-5.52,;4.05,-6.01,;2.72,-4.03,;4.08,-3.55,;3.02,-4.78,;12.1,-2.95,;12.07,-1.57,;13.48,-3.63,;14.76,-2.78,;14.67,-1.25,;15.43,.09,;14.65,1.43,;16.98,.11,;16.14,-3.47,;17.43,-2.62,;17.34,-1.25,;18.6,-.23,;20,-.92,;20.1,-2.46,;18.81,-3.31,)| Show InChI InChI=1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9.30	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50006842 (2-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-3-(3-isopropox...) Show SMILES CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O Show InChI InChI=1S/C27H24BrN3O2/c1-17(2)33-21-7-5-6-20(15-21)31-26(30-25-9-4-3-8-22(25)27(31)32)13-10-18-16-29-24-12-11-19(28)14-23(18)24/h3-9,11-12,14-17,29H,10,13H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Patents Similars	Article	n/a	n/a	9.30	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of [125 I]CCK-8 binding to Cholecystokinin type B receptor of mouse cerebral cortex				Bioorg Med Chem Lett 7: 805-810 (1997) Article DOI: 10.1016/S0960-894X(97)00108-X BindingDB Entry DOI: 10.7270/Q2XW4JTV
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063645 (CHEMBL9319 | N-(2-methoxyphenyl)-2-[3,4-dihydro-3-...) Show SMILES COc1ccccc1NC(=O)NNc1nc2ccccc2c(=O)n1-c1cccc(OC(C)C)c1 Show InChI InChI=1S/C25H25N5O4/c1-16(2)34-18-10-8-9-17(15-18)30-23(31)19-11-4-5-12-20(19)26-24(30)28-29-25(32)27-21-13-6-7-14-22(21)33-3/h4-16H,1-3H3,(H,26,28)(H2,27,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063667 (CHEMBL266120 | N-(3-methylphenyl)-2-[3,4-dihydro-3...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2cccc(C)c2)nc2ccccc2c1=O Show InChI InChI=1S/C25H25N5O3/c1-16(2)33-20-11-7-10-19(15-20)30-23(31)21-12-4-5-13-22(21)27-24(30)28-29-25(32)26-18-9-6-8-17(3)14-18/h4-16H,1-3H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062008 (CHEMBL342932 | [(R)-1-(Azepan-1-ylcarbamoyl)-2-(1H...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NN1CCCCCC1 |wU:1.13,wD:1.0,TLB:18:19:16.17.22:23,15:16:23:19.25.20,THB:18:17:23:19.25.20,20:21:16:19.18.25,20:19:16:21.22.23,(2.25,-7.79,;2.25,-9.16,;2.34,-10.7,;3.71,-11.41,;2.47,-12.32,;2.93,-13.79,;4.48,-13.79,;5.51,-14.93,;7.01,-14.61,;7.49,-13.14,;6.46,-12.01,;4.97,-12.32,;.87,-8.64,;-.41,-9.5,;-.39,-10.96,;-1.8,-8.81,;-3.09,-9.67,;-4.49,-9.09,;-5.84,-9.57,;-5.83,-11.05,;-7.04,-12.33,;-5.52,-11.91,;-5.54,-10.32,;-4.12,-12.48,;-3.1,-11.2,;-4.51,-11.55,;3.54,-8.48,;3.52,-7.1,;4.78,-9.22,;6.07,-8.36,;7.4,-9.16,;8.85,-8.6,;9.32,-7.14,;8.46,-5.85,;6.91,-5.72,;5.86,-6.84,)| Show InChI InChI=1S/C29H40N4O3/c1-29(27(34)32-33-10-6-2-3-7-11-33,17-23-18-30-25-9-5-4-8-24(23)25)31-28(35)36-26-21-13-19-12-20(15-21)16-22(26)14-19/h4-5,8-9,18-22,26,30H,2-3,6-7,10-17H2,1H3,(H,31,35)(H,32,34)/t19?,20?,21?,22?,26?,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50454908 (CHEMBL2112795) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@H]1CCCC[C@@H]1O |wU:34.40,wD:29.33,1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:21:16:19.18.25,20:19:16:21.23.22,15:16:22:19.18.20,(1.86,-7.02,;1.88,-8.39,;1.95,-9.94,;3.33,-10.64,;2.08,-11.55,;2.56,-13.03,;4.11,-13.02,;5.13,-14.17,;6.63,-13.85,;7.1,-12.37,;6.07,-11.24,;4.57,-11.55,;.49,-7.88,;-.8,-8.73,;-.77,-10.19,;-2.19,-8.04,;-3.48,-8.9,;-3.48,-10.43,;-4.89,-10.78,;-6.22,-10.29,;-7.41,-11.57,;-5.92,-11.15,;-4.51,-11.72,;-5.92,-9.55,;-4.87,-8.32,;-6.22,-8.8,;3.16,-7.71,;3.15,-6.33,;4.41,-8.44,;5.74,-7.68,;7.08,-8.44,;8.41,-7.69,;8.43,-6.14,;7.08,-5.37,;5.74,-6.13,;4.64,-5.03,)| Show InChI InChI=1S/C29H39N3O4/c1-29(27(34)31-24-8-4-5-9-25(24)33,15-21-16-30-23-7-3-2-6-22(21)23)32-28(35)36-26-19-11-17-10-18(13-19)14-20(26)12-17/h2-3,6-7,16-20,24-26,30,33H,4-5,8-15H2,1H3,(H,31,34)(H,32,35)/t17?,18?,19?,20?,24-,25-,26?,29+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063639 (CHEMBL9524 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C24H20ClN5O4/c1-2-34-22(32)15-6-5-7-17(14-15)26-24(33)29-28-23-27-20-9-4-3-8-19(20)21(31)30(23)18-12-10-16(25)11-13-18/h3-14H,2H2,1H3,(H,27,28)(H2,26,29,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063649 (CHEMBL9083 | N-(3-benzonitrile)-2-[3,4-dihydro-3-[...) Show SMILES CN(C)c1cccc(c1)-n1c(NNC(=O)Nc2cccc(c2)C#N)nc2ccccc2c1=O Show InChI InChI=1S/C24H21N7O2/c1-30(2)18-9-6-10-19(14-18)31-22(32)20-11-3-4-12-21(20)27-23(31)28-29-24(33)26-17-8-5-7-16(13-17)15-25/h3-14H,1-2H3,(H,27,28)(H2,26,29,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063652 (CHEMBL8997 | N-(4-chlorophenyl)-2-[3,4-dihydro-3-[...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2ccc(Cl)cc2)nc2ccccc2c1=O Show InChI InChI=1S/C24H22ClN5O3/c1-15(2)33-19-7-5-6-18(14-19)30-22(31)20-8-3-4-9-21(20)27-23(30)28-29-24(32)26-17-12-10-16(25)11-13-17/h3-15H,1-2H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063632 (CHEMBL9422 | N-(4-Bromophenyl)-2-[3,4-dihydro-3-[3...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2ccc(Br)cc2)nc2ccccc2c1=O Show InChI InChI=1S/C24H22BrN5O3/c1-15(2)33-19-7-5-6-18(14-19)30-22(31)20-8-3-4-9-21(20)27-23(30)28-29-24(32)26-17-12-10-16(25)11-13-17/h3-15H,1-2H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063613 (CHEMBL9291 | N-phenyl-2-[3,4-dihydro-3-[3-(1-methy...) Show SMILES CC(C)Oc1cccc(c1)-n1c(NNC(=O)Nc2ccccc2)nc2ccccc2c1=O Show InChI InChI=1S/C24H23N5O3/c1-16(2)32-19-12-8-11-18(15-19)29-22(30)20-13-6-7-14-21(20)26-23(29)27-28-24(31)25-17-9-4-3-5-10-17/h3-16H,1-2H3,(H,26,27)(H2,25,28,31)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063627 (CHEMBL9354 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OC)c2)c1 Show InChI InChI=1S/C25H23N5O5/c1-3-35-23(32)16-8-6-9-17(14-16)26-25(33)29-28-24-27-21-13-5-4-12-20(21)22(31)30(24)18-10-7-11-19(15-18)34-2/h4-15H,3H2,1-2H3,(H,27,28)(H2,26,29,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063626 (2-[2-(6-Bromo-1H-indol-3-yl)-ethyl]-3-(3-dimethyla...) Show SMILES CN(C)c1cccc(c1)-n1c(CCc2c[nH]c3cc(Br)ccc23)nc2ccccc2c1=O Show InChI InChI=1S/C26H23BrN4O/c1-30(2)19-6-5-7-20(15-19)31-25(29-23-9-4-3-8-22(23)26(31)32)13-10-17-16-28-24-14-18(27)11-12-21(17)24/h3-9,11-12,14-16,28H,10,13H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50449746 (CHEMBL2304063) Show SMILES [H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)C(OC(=O)N[C@@](C)(Cc1c[nH]c4ccccc14)C(=O)NCCc1ccccn1)[C@@]([H])(C2)C3 |wU:3.3,6.6,14.16,wD:37.41,1.0,TLB:8:6:40:1.39.2,8:1:40:9.6.5,THB:10:9:40:1.39.2,2:3:9:1.8.39,2:1:9:3.40.5,(9.27,-3.28,;10.78,-3.02,;9.99,-1.76,;10.9,-.65,;10.13,.67,;10.64,-2.25,;11.48,-3.6,;12.2,-4.96,;10.41,-4.75,;12.97,-3.35,;13.98,-4.49,;15.5,-4.18,;15.98,-2.72,;16.54,-5.32,;18.04,-4.99,;19.38,-4.22,;18.9,-2.94,;18.2,-1.17,;19.34,-.14,;18.71,1.27,;17.18,1.11,;16.04,2.14,;14.57,1.66,;14.25,.16,;15.4,-.87,;16.86,-.4,;19.08,-6.13,;18.61,-7.6,;20.59,-5.8,;21.62,-6.94,;23.13,-6.61,;24.17,-7.75,;23.7,-9.22,;24.74,-10.35,;26.24,-10.02,;26.71,-8.56,;25.67,-7.42,;13.18,-1.74,;14.68,-1.42,;12.16,-2.75,;12.39,-.42,)| Show InChI InChI=1S/C30H36N4O3/c1-30(17-23-18-33-26-8-3-2-7-25(23)26,28(35)32-11-9-24-6-4-5-10-31-24)34-29(36)37-27-21-13-19-12-20(15-21)16-22(27)14-19/h2-8,10,18-22,27,33H,9,11-17H2,1H3,(H,32,35)(H,34,36)/t19-,20+,21-,22+,27?,30-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description In vitro inhibition of [125I]- Bolton Hunter CCK-8 binding to Cholecystokinin type B receptor in the mouse cerebral cortex.				Bioorg Med Chem Lett 3: 2805-2810 (1993) Article DOI: 10.1016/S0960-894X(01)80769-1 BindingDB Entry DOI: 10.7270/Q29Z94TW
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062012 (CHEMBL344211 | [(R)-2-(1H-Indol-3-yl)-1-methyl-1-(...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NN1CCCCC1 |wU:1.13,wD:1.0,TLB:18:19:16.17.22:23,15:16:23:19.25.20,THB:18:17:23:19.25.20,20:21:16:19.18.25,20:19:16:21.22.23,(2.25,-7.79,;2.25,-9.16,;2.34,-10.7,;3.71,-11.41,;2.47,-12.32,;2.93,-13.79,;4.48,-13.78,;5.51,-14.93,;7.01,-14.61,;7.49,-13.14,;6.46,-12.01,;4.97,-12.32,;.87,-8.64,;-.41,-9.5,;-.39,-10.96,;-1.8,-8.81,;-3.09,-9.67,;-4.49,-9.09,;-5.84,-9.57,;-5.83,-11.05,;-7.04,-12.33,;-5.52,-11.91,;-5.54,-10.32,;-4.12,-12.48,;-3.1,-11.19,;-4.51,-11.55,;3.54,-8.48,;3.52,-7.1,;4.78,-9.22,;6.07,-8.36,;5.97,-6.82,;7.26,-5.98,;8.64,-6.67,;8.74,-8.2,;7.45,-9.06,)| Show InChI InChI=1S/C28H38N4O3/c1-28(26(33)31-32-9-5-2-6-10-32,16-22-17-29-24-8-4-3-7-23(22)24)30-27(34)35-25-20-12-18-11-19(14-20)15-21(25)13-18/h3-4,7-8,17-21,25,29H,2,5-6,9-16H2,1H3,(H,30,34)(H,31,33)/t18?,19?,20?,21?,25?,28-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50061999 (CHEMBL138952 | [(R)-1-(1-Benzyl-2-phenyl-ethylcarb...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)NC(Cc1ccccc1)Cc1ccccc1 |wU:1.13,wD:1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:19:16:21.23.22,20:21:16:19.18.25,15:16:22:19.18.20,(-.04,-9,;-.02,-10.36,;.05,-11.9,;1.43,-12.61,;.17,-13.52,;.65,-14.99,;2.2,-14.98,;3.21,-16.13,;4.72,-15.81,;5.2,-14.34,;4.17,-13.21,;2.67,-13.52,;-1.42,-9.85,;-2.7,-10.7,;-2.68,-12.16,;-4.08,-10.01,;-5.37,-10.87,;-5.38,-12.4,;-6.78,-12.75,;-8.1,-12.26,;-9.3,-13.53,;-7.8,-13.11,;-6.4,-13.68,;-7.81,-11.52,;-6.77,-10.29,;-8.13,-10.77,;1.25,-9.68,;1.24,-8.3,;2.63,-10.38,;3.91,-9.52,;5.29,-10.21,;6.79,-9.8,;7.16,-8.33,;8.63,-7.91,;9.73,-9,;9.35,-10.48,;7.86,-10.89,;3.82,-7.98,;5.1,-7.13,;6.48,-7.81,;7.77,-6.97,;7.67,-5.43,;6.27,-4.74,;5,-5.59,)| Show InChI InChI=1S/C38H43N3O3/c1-38(23-31-24-39-34-15-9-8-14-33(31)34,41-37(43)44-35-29-17-27-16-28(19-29)20-30(35)18-27)36(42)40-32(21-25-10-4-2-5-11-25)22-26-12-6-3-7-13-26/h2-15,24,27-30,32,35,39H,16-23H2,1H3,(H,40,42)(H,41,43)/t27?,28?,29?,30?,35?,38-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063648 (CHEMBL8922 | N-(3-methoxyphenyl)-2-[3,4-dihydro-3-...) Show SMILES COc1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OC(C)C)c2)c1 Show InChI InChI=1S/C25H25N5O4/c1-16(2)34-20-11-7-9-18(15-20)30-23(31)21-12-4-5-13-22(21)27-24(30)28-29-25(32)26-17-8-6-10-19(14-17)33-3/h4-16H,1-3H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50063630 (CHEMBL9188 | N-(3-ethylesterbenzoicacid)-2-[3,4-di...) Show SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OC(C)C)c2)c1 Show InChI InChI=1S/C27H27N5O5/c1-4-36-25(34)18-9-7-10-19(15-18)28-27(35)31-30-26-29-23-14-6-5-13-22(23)24(33)32(26)20-11-8-12-21(16-20)37-17(2)3/h5-17H,4H2,1-3H3,(H,29,30)(H2,28,31,35)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Compound was evaluated for functional activity on Cholecystokinin type B receptor (CCK-B) receptor carried out on guinea pig stomach cells.				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063646 (3-[3-({(3-Methoxy-phenyl)-[(methyl-phenyl-carbamoy...) Show SMILES COc1cccc(c1)N(CC(=O)N(C)c1ccccc1)C(=O)CNC(=O)Nc1cccc(c1)C(O)=O Show InChI InChI=1S/C26H26N4O6/c1-29(20-10-4-3-5-11-20)24(32)17-30(21-12-7-13-22(15-21)36-2)23(31)16-27-26(35)28-19-9-6-8-18(14-19)25(33)34/h3-15H,16-17H2,1-2H3,(H,33,34)(H2,27,28,35)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50063642 (CHEMBL9311 | N-(4-methoxyphenyl)-2-[3,4-dihydro-3-...) Show SMILES COc1ccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(OC(C)C)c2)cc1 Show InChI InChI=1S/C25H25N5O4/c1-16(2)34-20-8-6-7-18(15-20)30-23(31)21-9-4-5-10-22(21)27-24(30)28-29-25(32)26-17-11-13-19(33-3)14-12-17/h4-16H,1-3H3,(H,27,28)(H2,26,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
Parke-Davis Pharmaceutical Research Curated by ChEMBL					Assay Description Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]-Bolton Hunter CCK-8 as radioligand				J Med Chem 41: 1042-9 (1998) Article DOI: 10.1021/jm970373j BindingDB Entry DOI: 10.7270/Q2TQ60N3
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (MOUSE)	BDBM50062015 (CHEMBL139601 | [(R)-1-((1S,2S)-2-Hydroxy-cyclohept...) Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@H]1CCCCC[C@@H]1O |wU:1.13,35.41,wD:29.33,1.0,TLB:25:24:22:19.18.20,THB:25:19:16.24.23:22,20:21:16:19.18.25,20:19:16:21.23.22,15:16:22:19.18.20,(10.61,-3.24,;10.63,-4.59,;10.7,-6.14,;12.08,-6.84,;10.84,-7.75,;11.31,-9.23,;12.86,-9.23,;13.89,-10.38,;15.38,-10.05,;15.85,-8.57,;14.82,-7.45,;13.32,-7.75,;9.25,-4.08,;7.97,-4.95,;7.99,-6.4,;6.56,-4.24,;5.27,-5.11,;5.27,-6.63,;3.87,-6.98,;2.54,-6.49,;1.34,-7.78,;2.84,-7.36,;4.24,-7.92,;2.84,-5.77,;3.89,-4.52,;2.54,-5.02,;11.92,-3.92,;11.9,-2.54,;13.16,-4.64,;14.49,-3.89,;15.78,-4.76,;17.26,-4.29,;17.82,-2.86,;17.05,-1.53,;15.52,-1.3,;14.38,-2.32,;12.95,-1.76,)| Show InChI InChI=1S/C30H41N3O4/c1-30(16-22-17-31-24-8-6-5-7-23(22)24,28(35)32-25-9-3-2-4-10-26(25)34)33-29(36)37-27-20-12-18-11-19(14-20)15-21(27)13-18/h5-8,17-21,25-27,31,34H,2-4,9-16H2,1H3,(H,32,35)(H,33,36)/t18?,19?,20?,21?,25-,26-,27?,30+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
Warner-Lambert Company Curated by ChEMBL					Assay Description Inhibitory concentration against radioligand [125I]Bolton-Hunter labeled CCK-8 to cholecystokinin type B receptor in the mouse cerebral cortex				J Med Chem 41: 38-45 (1998) Article DOI: 10.1021/jm970065l BindingDB Entry DOI: 10.7270/Q2GT5NV6
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 240 total )  |  Next  |  Last  >>

Jump to: